Showing results (241-250 of 566) with videos related to

Sort By:
Pageof 57
Rheumatology (Oxford, England)|February 2, 2023
Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritisGerd R Burmester, Vibeke Strand, Alan J Kivitz, et al.
RMD Open|June 30, 2018
Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritisVibeke Strand, Margaret Michalska, Christine Birchwood, et al.
Lupus Science & Medicine|July 7, 2026
Qualitative interview study in patients with SLE to assess patient perception of fatigue and skin-related symptomsJoseph F Merola, Victoria P Werth, Jiyoon C Choi, et al.
Arthritis Research & Therapy|June 11, 2020
Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXTVibeke Strand, Janet Pope, Namita Tundia, et al.
Annals of the Rheumatic Diseases|August 7, 2013
Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extensionEdward Keystone, Robert Landewé, Ronald van Vollenhoven, et al.
Clinical Therapeutics|July 9, 2021
Risk of Thromboembolic Events and Associated Risk Factors, Including Treatments, in Patients with Immune-mediated DiseasesJuliana Setyawan, Fan Mu, Andres Yarur, et al.
Autoimmunity|May 23, 2007
Engulfed cell remnants, and not cells undergoing apoptosis, constitute the LE-cell phenomenonEva Feierl, Josef S Smolen, Thomas Karonitsch, et al.
Annals of the Rheumatic Diseases|August 24, 2012
Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritisKatja Thiele, Dörte Huscher, Sascha Bischoff, et al.
Therapeutic Advances in Musculoskeletal Disease|April 4, 2022
A glimpse into the future of systemic lupus erythematosusMartin Aringer, Marta E Alarcón-Riquelme, Megan Clowse, et al.
RMD Open|October 1, 2019
Measurement properties of the minimal disease activity criteria for psoriatic arthritisLaura C Coates, Vibeke Strand, Hilary Wilson, et al.
Pageof 57